These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 14406839)
1. [Attempted prevention of measles by means of intra-ocular instillation of convalescent sera. Preliminary communication]. JAROSZYNSKA-WEINBERGER B Pediatr Pol; 1960 Mar; 35():345-52. PubMed ID: 14406839 [No Abstract] [Full Text] [Related]
2. [Attempted prevention of measles in child centers by means of instillation of convalescent serum in the eyes (preliminary communication)]. JAROSZYNSKA-WEINBERGER B Arch Fr Pediatr; 1960; 17():509-15. PubMed ID: 14406838 [No Abstract] [Full Text] [Related]
3. [Supplementary data on utilization of serum against measles in production of gamma globulin]. KHAIT SL; LUPINA MI Zh Mikrobiol Epidemiol Immunobiol; 1955 Jul; (7):15-9. PubMed ID: 13257784 [No Abstract] [Full Text] [Related]
4. [Serum agglutination by convalescent sera of erythrocytes during the course of measles]. LOZOVSKAIA LS Vopr Virusol; 1958; 3(4):242-3. PubMed ID: 13593294 [No Abstract] [Full Text] [Related]
5. Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus. Wechsler SL; Weiner HL; Fields BN J Immunol; 1979 Aug; 123(2):884-9. PubMed ID: 458157 [TBL] [Abstract][Full Text] [Related]
7. [Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines]. Kuwajima S Hokkaido Igaku Zasshi; 1986 Jan; 61(1):5-14. PubMed ID: 3699682 [TBL] [Abstract][Full Text] [Related]
9. [Prophylaxis and treatment of measles with convalescent serum intradermally]. ALVAREZ RIANO AM Pediatr Am; 1947 Jan; 5(1):40-6. PubMed ID: 20239918 [No Abstract] [Full Text] [Related]
10. [Contribution to measles prophylaxis by intradermal injection of convalescent serum]. VELEZ HA Pediatr Am; 1947 Feb; 5(2):65-7. PubMed ID: 20239922 [No Abstract] [Full Text] [Related]
11. [Current problems of measles]. Budai J Orv Hetil; 1970 Feb; 111(7):363-8. PubMed ID: 4906169 [No Abstract] [Full Text] [Related]
12. [Value of specific serum prophylaxis in the South Greenland measles epidemic 1951]. CHRISTENSEN PE; SCHMIDT H Ugeskr Laeger; 1953 May; 115(20):779-86. PubMed ID: 13077992 [No Abstract] [Full Text] [Related]
14. Correlation between canine distemper and measles virus neutralizing capacities in human sera. CARLSTROM G Arch Gesamte Virusforsch; 1959; 8(5):539-48. PubMed ID: 13650526 [No Abstract] [Full Text] [Related]
15. Sensitizing versus immunizing properties of inactivated measles vaccine. Wilson S; Aprile MA Prog Immunobiol Stand; 1970; 4():657-60. PubMed ID: 4991597 [No Abstract] [Full Text] [Related]
16. [INVESTIGATIONS ON THE MECHANISM OF IMMUNITY TO MEASLES]. ENDERS-RUCKLE G Zentralbl Bakteriol Orig; 1963 Dec; 191():217-36. PubMed ID: 14119909 [No Abstract] [Full Text] [Related]
17. Titers of complement fixing measles antibodies in sera collected at random from healthy persons in Copenhagen. BECH V Acta Pathol Microbiol Scand; 1960; 50():322-30. PubMed ID: 13688355 [No Abstract] [Full Text] [Related]
18. Titers of complement fixing measles antibodies in human sera collected from one to five years after illness. BECH V Acta Pathol Microbiol Scand; 1960; 50():81-8. PubMed ID: 13688354 [No Abstract] [Full Text] [Related]
19. Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway. Joseph BS; Cooper NR; Oldstone MB J Exp Med; 1975 Apr; 141(4):761-74. PubMed ID: 1092789 [TBL] [Abstract][Full Text] [Related]
20. Convalescent whole blood, plasma and serum in the prophylaxis of measles: JAMA, 12 April, 1926; 1180-1187. Zingher A; Mortimer P Rev Med Virol; 2005; 15(6):407-18; discussion 418-21. PubMed ID: 16211552 [No Abstract] [Full Text] [Related] [Next] [New Search]